The TELIGEN System tower offers a suite of technologies. Credit: DePuy Synthes / PRNewswire.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for DePuy Synthes’ TELIGEN System, a combined technology platform.

Using digital tools for access and view, TELIGEN facilitates less invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures.

Related Company Profiles

View all

The system includes a tower that offers various technologies, including a VueLIF-T Procedure Kit with a disposable HD camera, a camera control system, a TELIGEN Clear Discectomy Device and disposable ports.

The digitally equipped TELIGEN VUE Camera of the platform removes the requirement for a microscope and can offer an unhindered visualisation of the surgical site.

It enables multidirectional, expanded and hands-free view during the procedure.

See Also:

Surgeons could adjust the image clarity as per their preference using the self-cleaning camera, which also has LED lighting.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Additionally, the system merges with the UNLEASH bundle of implant solutions, which is created to simplify the key MIS-TLIF stages.

As against current MIS technologies, the TELIGEN System could be efficient and cost-effective for hospitals.

The system was demonstrated to lower fluoroscopy time by 47% versus MIS-TLIF procedures carried out using a surgical microscope in a cadaveric study.

The company anticipates making the system available in the country later this year.

DePuy Synthes Spine worldwide president Russell Powers said: “Improving the MIS spinal surgery experience for both patients and surgeons is a critical step to addressing unmet needs in the industry.

“With our groundbreaking TELIGEN Technology Platform, we’re providing a better field of view to help improve patient care and increase efficiencies.”

In November last year, the company introduced the UNIUM System for small bone, sports medicine, spine and thorax procedures.